3 Einträge von 4 mit deficiency patients
www.cslbehring.ch
Datum der Indexierung 25.04.2021 00:30:17
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz |
weitere Namen in www.cslbehring.ch 4
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase patient | products rviii | with research | hizentra immunoglobulins | patients from | development haemophilia | clinical plasma | study vaccine | rix-fp specialty | safety briefing |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency and clinical evidence of emphysema Has been shown to slow the progression of emphysema as measured by CT lung density DNA1 is the first and only test to confirm known and unknown variants of alpha-1 proteinase inhibitor Zemaira® • Approxim patients and patient samples • Model for Biotech / Pharma Research • decentralisation into high quality academic research hubs Bio21 - Research Hub • Located within world class university, medical research and hospital precinct in
Text Inhalt Text aus URL
Log Metriken 563120
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz |
weitere Namen in www.cslbehring.ch 4
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase patient | products rviii | with research | hizentra immunoglobulins | patients from | development haemophilia | clinical plasma | study vaccine | rix-fp specialty | safety briefing |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency and clinical evidence of emphysema Has been shown to slow the progression of emphysema as measured by CT lung density DNA1 is the first and only test to confirm known and unknown variants of alpha-1 proteinase inhibitor Zemaira® • Approxim patients and patient samples • Model for Biotech / Pharma Research • decentralisation into high quality academic research hubs Bio21 - Research Hub • Located within world class university, medical research and hospital precinct in
Text Inhalt Text aus URL
Log Metriken 563120
www.cslbehring.ch
Datum der Indexierung 05.05.2021 16:44:47
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=6A9CD360662B6CDEDCAE1B016E11BD8F68ED4E2B
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency patients in Japan PID network (2014) • Currently Hizentra® and 5% IVIG available to patients • CSL will bring first high purity room temperature 10% IVIG product to Japan • Commence Privigen® PID study Q3/4 2016 o Agreement on study design patients Product Features Phase Manufacturer Half-life extension Eloctate rFVIII fused to Fc Market Biogen Idec N8-GP BDD FVIII O-linked pegyln Ph II/III Novo Nordisk BAX 855 FVIII Lys-linked pegyln Market Baxter 1.1 - 1.5 fold* B
Text Inhalt Text aus URL
Log Metriken 446196
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf?la=fr-fr&hash=6A9CD360662B6CDEDCAE1B016E11BD8F68ED4E2B
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency patients in Japan PID network (2014) • Currently Hizentra® and 5% IVIG available to patients • CSL will bring first high purity room temperature 10% IVIG product to Japan • Commence Privigen® PID study Q3/4 2016 o Agreement on study design patients Product Features Phase Manufacturer Half-life extension Eloctate rFVIII fused to Fc Market Biogen Idec N8-GP BDD FVIII O-linked pegyln Ph II/III Novo Nordisk BAX 855 FVIII Lys-linked pegyln Market Baxter 1.1 - 1.5 fold* B
Text Inhalt Text aus URL
Log Metriken 446196
www.cslbehring.ch
Datum der Indexierung 13.03.2021 22:41:22
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz |
weitere Namen in www.cslbehring.ch 4
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase patient | products dosing | with rviii | patients research | hizentra activity | clinical immunoglobulins | development haemophilia | study specialty | plasma vaccine | safety rix-fp |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency and clinical evidence of emphysema Has been shown to slow the progression of emphysema as measured by CT lung density DNA 1 is the first and only test to confirm known and unknown variants of alpha-1 proteinase inhibitor Zemaira ® • Approx patients and patient samples • Model for Biotech / Pharma Research • decentralisation into high quality academic research hubs Bio21 - Research Hub • Located within world class university, medical research and hospital precinct in
Text Inhalt Text aus URL
Log Metriken 446272
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz |
weitere Namen in www.cslbehring.ch 4
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords phase patient | products dosing | with rviii | patients research | hizentra activity | clinical immunoglobulins | development haemophilia | study specialty | plasma vaccine | safety rix-fp |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
deficiency and clinical evidence of emphysema Has been shown to slow the progression of emphysema as measured by CT lung density DNA 1 is the first and only test to confirm known and unknown variants of alpha-1 proteinase inhibitor Zemaira ® • Approx patients and patient samples • Model for Biotech / Pharma Research • decentralisation into high quality academic research hubs Bio21 - Research Hub • Located within world class university, medical research and hospital precinct in
Text Inhalt Text aus URL
Log Metriken 446272